What is the appropriate Augmentin (amoxicillin/clavulanate) dosing regimen for adult community‑acquired pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing for Community-Acquired Pneumonia in Adults

For adults with community-acquired pneumonia and comorbidities (chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancy; or asplenia), use Augmentin 875 mg/125 mg twice daily OR 500 mg/125 mg three times daily OR 2000 mg/125 mg twice daily (extended-release formulation), combined with a macrolide or doxycycline. 1

Patient Stratification and Dosing

Healthy Outpatients Without Comorbidities

  • Augmentin is NOT the first-line choice for this population
  • Plain amoxicillin 1 g three times daily is preferred (strong recommendation) 1
  • Reserve Augmentin for patients with comorbidities (see below)

Outpatients With Comorbidities

Use one of these Augmentin regimens WITH a macrolide or doxycycline:

  • Augmentin 875 mg/125 mg twice daily (most convenient), OR
  • Augmentin 500 mg/125 mg three times daily, OR
  • Augmentin 2000 mg/125 mg twice daily (extended-release formulation for enhanced pharmacokinetics)

1

Combination partner options:

  • Azithromycin 500 mg day 1, then 250 mg daily, OR
  • Clarithromycin 500 mg twice daily, OR
  • Doxycycline 100 mg twice daily

The 2019 ATS/IDSA guidelines provide a strong recommendation with moderate-quality evidence for this combination therapy approach in patients with comorbidities 1.

Alternative Monotherapy Option

  • Respiratory fluoroquinolone alone (levofloxacin 750 mg daily OR moxifloxacin 400 mg daily) is an acceptable alternative to Augmentin-based combination therapy (strong recommendation, moderate evidence) 1

Duration of Therapy

The 2026 ATS guidelines recommend shorter antibiotic courses based on clinical stability:

  • Minimum 3 days for outpatients and hospitalized patients with nonsevere CAP who achieve clinical stability 2
  • Continue until clinical stability is achieved, then stop (rather than arbitrary 5-7 day courses)
  • 5 days or greater for severe CAP (strong recommendation) 2

Clinical stability criteria (ALL must be met):

  • Temperature <37.8°C
  • Heart rate <100 beats/minute
  • Respiratory rate <24 breaths/minute
  • SpO₂ >90% on room air (or baseline oxygen requirement)
  • Systolic blood pressure >90 mmHg
  • Normal mental status

2

Critical caveat: Assess stability daily—do not prescribe a fixed duration upfront. Many hospitalized patients (>50%) will NOT qualify for short courses due to comorbidities or delayed stability 2.

Evidence Supporting High-Dose Augmentin

The 2000 mg/125 mg twice-daily extended-release formulation is pharmacokinetically enhanced to maintain higher amoxicillin serum concentrations, providing coverage against Streptococcus pneumoniae with MICs up to 4 mg/L (penicillin-resistant strains) 3, 4.

  • Clinical success rates: 91.5% at test of cure 3
  • Bacteriological success: 96% for penicillin-resistant S. pneumoniae 4
  • Well-tolerated with similar adverse event rates to standard dosing 3

Important Pitfalls to Avoid

  1. Do NOT use Augmentin as monotherapy in patients with comorbidities—combination with macrolide/doxycycline is essential for atypical pathogen coverage 1

  2. Do NOT use macrolide monotherapy in areas with >25% pneumococcal macrolide resistance (most of the United States) 1

  3. Do NOT prescribe fixed 7-10 day courses—the 2026 guidelines emphasize daily reassessment and stopping at clinical stability 2

  4. Ensure close follow-up when using 3-day courses—patients need clear instructions on signs of recurrence (fever, tachycardia, dyspnea, altered mental status) and established communication plans 2

  5. Consider renal/hepatic function when determining effective treatment duration, particularly for patients with renal insufficiency 2

  6. Take with food to minimize gastrointestinal intolerance and enhance clavulanate absorption 5

Severe CAP Considerations

For patients meeting severe CAP criteria (requiring ICU admission, vasopressors, or mechanical ventilation):

  • Do NOT use short-course therapy—maintain ≥5 days of antibiotics 2
  • Higher risk of treatment failure, resistant organisms, and disseminated infection necessitates longer treatment 2
  • Recent data shows 83.5% AMC susceptibility in severe CAP isolates, rising to 90.9% in patients without recent antibiotic exposure 6

Related Questions

What is the recommended adult dosing of amoxicillin‑clavulanate (including high‑dose and alternative regimens) for treating community‑acquired pneumonia in an otherwise healthy adult?
Can oral amoxicillin 2 g twice daily be given to adult patients?
How should Augmentin (amoxicillin‑clavulanate) be dosed for an adult with community‑acquired pneumonia, including oral and intravenous regimens, renal function adjustments, and alternatives if contraindicated?
Which antibiotic is appropriate for treating community-acquired pneumonia in a patient who developed a rash to Augmentin (amoxicillin‑clavulanate)?
What is the appropriate Augmentin (amoxicillin + clavulanate) dosage for an 89‑year‑old patient being treated for community‑acquired pneumonia with normal renal function?
Why must the insulin infusion be continued even when blood glucose becomes low in hyperosmolar hyperglycemic state (HHS) and diabetic ketoacidosis (DKA)?
Can you help me organize a PowerPoint presentation on schizoaffective disorder and bipolar disorder for psychiatrists?
For which clinical conditions are the following laboratory tests typically ordered: serum or urine osmolality, urine protein‑creatinine ratio, spot urine sodium, 24‑hour urine sodium, and random (spot) urine sodium?
What does an elevated thyroid-stimulating hormone (TSH) level indicate?
What is the recommended treatment for a patient presenting with painful acne?
In a postpartum woman presenting with right upper‑quadrant pain and dizziness, what is the appropriate evaluation and initial management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.